Descartes Systems vs Manhattan Associates
DSGX and MANH side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DSGX and MANH compare
Descartes Systems grew revenue faster over the last twelve months (12.0% versus 8.4% for Manhattan Associates).
Descartes Systems keeps more of each dollar of sales as profit, with a net margin of 22.5% compared with 18.4% at Manhattan Associates.
Manhattan Associates scores higher on the StockData Score (16 against 14 for Descartes Systems), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DSGX | MANH |
|---|---|---|
| Size and price | ||
| Market cap | – | $14.5B |
| Share price | $90.62 | $248.39 |
| Change, 1 year | 0.99% | 39.3% |
| Change, 5 years | 9.9% | 37.9% |
| Beta (5Y) | 0.86 | 1.24 |
| Employees | 45 | 4,370 |
| StockData Score | ||
| Total score | 14 | 16 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 4 (better) | 3 |
| Performance score | 5 | 5 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 69.6× |
| P/S | – | 12.5× |
| P/B | – | 72.1× |
| EV/EBITDA | – | 50.0× |
| P/FCF | – | 38.2× |
| PEG | – | 3.31 |
| FCF yield | – | 2.6% |
| Fair value | – | $155.92 |
| Margin of safety | – | −59.3% |
| Growth | ||
| Revenue growth (TTM) | 12.0% (better) | 8.4% |
| Revenue growth, 5Y average | 15.9% (better) | 13.0% |
| Net income growth (TTM) | 14.3% (better) | −1.4% |
| EPS growth (TTM) | 14.0% (better) | 1.7% |
| EPS growth, 5Y average | 25.1% (better) | 21.5% |
| Profitability | ||
| Gross margin | 77.1% (better) | 55.9% |
| Operating margin | 28.8% (better) | 24.1% |
| Net margin | 22.5% (better) | 18.4% |
| FCF margin | 35.7% (better) | 32.8% |
| Return on equity | 10.4% | 83.5% (better) |
| Return on invested capital | 12.6% | 880% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | 217× | – |
| Current ratio | 2.02 (better) | 1.07 |
| Altman Z-score | – | 19.06 |
| Piotroski F-score | 8 (better) | 7 |
| Dividends and buybacks | ||
| Buyback yield | – | 3.0% |
| Shareholder yield | – | 3.0% |
| Ownership | ||
| Held by institutions | 82.0% | 110% |
| Held by insiders | 0.00% | 1.4% |
| Insider net buying, 12 months | – | −$3.3M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 1.8% | 5.6% |
Go deeper
- DSGX stock overview
- DSGX income statement
- DSGX valuation and score
- MANH stock overview
- MANH income statement
- MANH valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.